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 Objective: This study aimed to establish whether psychiatric patients’ subjective 
initial response (SIR) to hospital and day hospital treatment predicts outcomes over a 
one year follow-up period.  
Method: We analysed data from 765 patients who were randomised to acute 
psychiatric treatment in a hospital or day hospital. SIR was assessed on day three 
after admission. Outcomes were psychiatric symptom levels and social disability at 
discharge, and at 3 and 12 months after discharge.  
Results: After controlling for socio-demographic and clinical characteristics, a more 
positive SIR was significantly associated with lower symptom levels at discharge and 
3 months after discharge, and lower social disability at 3 months and 12 months after 
discharge.  
Conclusion: SIR can predict outcomes of complex interventions over a one year 
period. Patients’ initial views of acute hospital and day treatment should be elicited 
and considered as important.   
 
 
 
 
 
 
 
 
 
 
                                        
 Introduction 
 
The concept of subjective initial response (SIR), defined as patients’ initial 
assessment of the appropriateness and effects of their treatment, originated from 
psychopharmacology studies conducted in the 1970s. Van Putten and May found 
that the SIR of patients with schizophrenia to neuroleptic medication was significantly 
associated with clinical outcome at the end of a four week treatment period (27). 
Patients who stated within two days of a new treatment that they believed their 
medication to be right for them and helpful had lower symptom levels at the end of 
treatment, a finding that was repeatedly replicated (1, 2, 25, 26).  
 
The idea that patients’ SIR may predict outcome was subsequently extended to 
complex interventions. A first publication showed that a more positive SIR of 
depressed patients to psychiatric hospital treatment was correlated with lower 
symptom levels four months after admission (14). Further studies suggested that SIR 
may also predict the outcome of hospital and day hospital treatment in patients with 
schizophrenia (3, 17). The predictive value of SIR was independent of patients’ initial 
symptom improvement (17, 18) and their psychiatrist’s expectations regarding the 
likely success of treatment (18).  
 
All these studies assessed patients’ SIR within a maximum of three days after 
admission and found a significant association of more positive SIR with more positive 
outcomes. However, this research has serious limitations. All studies were single site 
studies in the same country (Germany) and had relatively small sample sizes (up to a 
maximum of n = 63 (18)). Only one study assessed outcome beyond discharge, using 
a four month follow-up period (14).  Patient characteristics as potentially confounding 
variables were not controlled for in any study. Thus, there is not yet sufficient 
 evidence for a generalised conclusion that asking patients for their views of treatment 
shortly after admission really provides information that is predictive of outcomes.  
 
The European Day Hospital Evaluation (EDEN) study, a randomised controlled trial 
of acute inpatient versus day hospital treatment conducted across five European 
countries (11), presented an ideal opportunity to improve on existing research by 
assessing the association between SIR to hospital or day hospital treatment and 
outcome in a large multi-national sample including three major diagnostic groups. 
 
Objectives 
The present study aimed to assess the association of SIR to acute hospital or day 
hospital treatment with levels of symptoms and social disability at discharge, and at 3 
months and 12 months after discharge. We hypothesised that a more positive SIR 
would predict more favourable outcomes independently of socio-demographic and 
clinical characteristics of the patients, and that the predictive association would not 
differ between hospital and day hospital treatment or across major diagnostic groups.  
 
Subjects and methods 
 
Study Design 
The present study used data from the EDEN study, a multi-centre randomised 
controlled trial comparing acute treatment in day hospitals with that on conventional 
inpatient wards in five European countries (Prague, Czech Republic; Dresden, 
Germany; Wroclaw, Poland; Michalovce, Slovakia; London, United Kingdom). The 
EDEN study found more favourable outcomes for social disability in day hospitals, 
and no difference in terms of symptoms or subjective quality of life (11). Here, we 
analysed the association between SIR and outcomes at discharge, 3 months post-
discharge, and 12 months post-discharge.  
  
Sample 
All patients aged between 18 and 65 years who were in need of acute treatment in a 
psychiatric facility in one of the five centres during the study period were eligible to 
participate in the EDEN study. Exclusion criteria were an admission only for 
diagnostic purposes; involuntary admission; likely requirement of coercive measures 
or consistent one-to-one observation; acute intoxication; a somatic disorder requiring 
inpatient care; direct referral from another hospital; homelessness; one-way journey 
to the day hospital of more than 60 minutes or requirement to be consistently 
accompanied on the way to and from the day hospital; incapacity to give informed 
consent or not giving informed consent. Study participants were randomised to acute 
treatment either in a day hospital or on a conventional inpatient ward. After complete 
description of the study to the potential participants, written informed consent was 
obtained. The study was approved by the relevant ethics committees. Details of the 
rationale, settings, methods and main findings of the study have been published 
elsewhere (11).  
 
Of the 1117 patients participating in EDEN (10), those with unclear or infrequent 
diagnoses were excluded so that we could analyse three major psychiatric diagnostic 
categories (ICD-10 F20-29, F30-39 and F40-59) as potentially influential factors, 
leaving a total of 765 patients included in the present analysis. In line with clinical 
practice at participating centres, clinical diagnoses were made according to ICD-10.  
 
Outcome Measures 
For this analysis we used the primary observer-rated outcome criteria of the EDEN 
study, i.e. psychiatric symptom levels and social disability at discharge, and at 3 and 
12 months after discharge. Self-reported outcome criteria were not included in this 
 analysis in order to avoid the potentially confounding covariance between self-
reported predictors and self-reported outcomes (5, 6, 19).   
 
Psychiatric symptom levels were assessed with the 24-item version (4.0) of the Brief 
Psychiatric Rating Scale (BPRS) (28). The inter-rater reliability achieved in the 
training of researchers in the study was 0.78 (intra-class correlation, ICC). Social 
disability was rated on the Groningen Social Disability Schedule, Second Revision 
(GSDS) (29). On the GSDS disabilities are rated in 8 social roles, with disability in 
each role ranging from 0 (“no disability”) to 3 (“severe disability”), and a sum score is 
then computed. The inter-rater reliability for the sum score in this study was 0.77 
(ICC) (24).  
 
Subjective Initial Response 
SIR was assessed on day 3 of admission, i.e. about two days after admission, since 
the day of admission counts as day 1. It was measured on the Client Assessment of 
Treatment Scale (CAT) (16). On the CAT, patients’ rate their satisfaction with and 
appropriateness of treatment using a scale from 0 ("not at all") to 10 “yes, entirely”, 
on seven dimensions: “Do you believe you are receiving the right treatment/care for 
you here?”, “Does your psychiatrist understand you and is he/she engaged in your 
treatment/care?”, “Are relations with other staff members here pleasant for you?”, 
“Do you believe you are receiving the right medication for you?”, “Do you believe the 
other elements of treatment/ care here are right for you?”, “Do you feel respected and 
regarded well here?”, and “Has treatment/care here been helpful for you?”.  The 
scale has been found to have an internal consistency of 0.90 in a previous large 
study in psychiatric inpatients (20). The mean score was used as the measure of 
SIR.  
 
 
 Other potential predictors 
Other potential predictors assessed were gender, living status (living alone versus 
with someone), employment status, age, education level, and the main psychiatric 
diagnosis according to ICD-10 (9). The variables were selected based on previous 
studies on SIR and clinical outcomes in similar patient groups (7, 8, 13). Socio-
demographic variables were assessed using the Client Socio-demographic and 
Clinical History Schedule (12). As a complete standardized diagnostic interview with 
all patients was impracticable in the case of acute admissions, we used the clinical 
discharge diagnosis in all cases.  The main diagnoses were analysed in three 
categories, a) schizophrenia, schizotypal and delusional disorders (ICD: F20-29); b) 
mood disorders (F30-39); and c) neurotic, stress related and somatoform disorders, 
and behavioural syndromes associated with physiological disturbances and physical 
factors (F40-59).  
 
Procedure 
All predictor and outcome variables were assessed by researchers who had no 
involvement in treatment. Potential predictor variables other than the clinical 
diagnosis and SIR were assessed before randomly assigning participants to either 
inpatient or day hospital treatment.  SIR was assessed on day 3 of admission. 
Outcome measures were assessed at admission, at discharge, and at 3 month and 
12 month follow ups after discharge.  
 
Statistical Method 
Mixed model analyses were conducted separately at discharge, 3 months and 12 
months to determine over which period of time SIR may predict outcomes. The two 
outcome variables, BPRS and GSDS, were analysed in separate models. Patient 
characteristics were included in the mixed model analyses as main effects so that the 
predictive association of SIR and outcomes was adjusted for the influence of those 
 variables. The baseline measurement of BPRS and GSDS respectively, the 
treatment setting (hospital versus day hospital), the length of stay in the hospital or 
day hospital and the study centre (i.e. the national site of data collection in the EDEN 
trial) were controlled for in all multivariate analyses as potential confounders. All of 
these factors and the SIR were introduced as fixed effects whereas the patient was 
treated as a random effect. In a second step, potential interaction effects of the 
treatment setting (i.e. hospital versus day hospital) and diagnostic category with SIR 
in predicting outcomes were tested to assess whether the predictive association of 
SIR significantly differed between the two settings or across the three diagnostic 
groups. 
 
During the trial, some patients dropped out, resulting in incomplete observations. 
These incomplete observations were not computed but assumed to be missing at 
random in the mixed effect model analysis. Additionally, the SIR of participants who 
dropped out was compared to the SIR of those who did not, to explore whether they 
differed.  
 
All statistical analyses were carried out using Statistical Analysis System (SAS) 
version 9.1 (23)  
 
 
Results 
 
Sample characteristics 
The characteristics of the sample are summarised in Table 1.  
 
[Insert Table 1 about here] 
 
 Of the total sample of 765 patients, 374 were admitted to conventional wards, and 
391 to day hospitals. The majority of patients were female, and each of the three 
diagnostic groups (ICD-10 F20-F29, F30–F39, and F40-F59) represented more than 
a quarter of the sample. The mean score on the CAT on day three was 7.6.  
Of all patients recruited at baseline, 87% were followed up at discharge, 78% after 3 
months, and 69% after 12 months (4) 
 
Clinical Outcomes 
Table 2 presents levels of the outcome measures at four time points: baseline, 
discharge, three months after discharge, and twelve months after discharge.  
 
[Insert Table 2 about here] 
 
Symptom levels substantially reduced between baseline and discharge. Levels 
fluctuated between discharge and 12 months follow-up, but were at all post baseline 
measurements significantly less severe than at baseline. The score on the GSDS at 
baseline was 9.37, and significantly improved over time.   
 
Association of SIR with subsequent symptom levels 
The mixed models analyses computing the association between SIR and psychiatric 
symptom levels at discharge, 3 months after discharge and 12 months after 
discharge are outlined in Table 3.   
 
[Insert Table 3 about here] 
 
A more positive SIR was a significant predictor of lower symptom levels at discharge 
(p<0.01) and at 3 months after discharge (p=0.02), and showed a trend towards 
 predicting lower symptoms levels at 12 months after discharge, which however failed 
to reach statistical significance (p = 0.06).  
 
Other significant predictors of symptom levels included age (significant positive 
association at 3 months after discharge), employment status (unemployment 
associated with increased psychiatric symptom levels at 3 months after discharge), 
baseline psychiatric symptom levels (significant positive association at all time 
points), and main psychiatric diagnosis (F2 associated with higher symptom levels at 
3 months and 12 months after discharge). However, the predictive value of SIR was 
independent of the influence of these characteristics.  
 
Association of SIR with subsequent social disability 
The mixed model analyses of the association between SIR and social disability at 
discharge, at 3 months and at 12 months discharge are outlined in Table 4.  
 
[Insert table 4 about here] 
 
A more positive SIR was significantly associated with lower social disability at 3 
months (p = 0.01) and 12 months after discharge (p = 0.03).  
 
Another significant predictor of social disability was the main psychiatric diagnosis 
(F2 associated with increased social disability at 12 months). Again, the predictive 
value of SIR was independent of this factor.  
 
Interactions of SIR with treatment setting and main psychiatric diagnosis 
The interactions between SIR and treatment setting as well as diagnostic group were 
found to be non-significant in predicting symptom levels and social disability at all 
 time points. Thus, there is no evidence that the association of SIR with outcomes 
varied between hospital and day hospital or across diagnostic groups.  
 
 Comparison of research dropouts to completers 
Of the original 765 participants, 37 dropped out, i.e. did not complete any follow-up 
assessments. T-tests demonstrated that there was a significant difference between 
the SIR of research completers and research dropouts, with the mean SIR higher in 
completers. The effect size was small, with completer status explaining around 1% of 
the variance in CAT score (t = -2.7, d.f. = 764, p = 0.007, Partial η2 = 0.01).  
 
Discussion 
 
In a large multinational sample, patients’ SIR to acute hospital and day hospital 
treatment was associated with outcomes over a one year period. A more positive SIR 
predicted lower symptom levels at discharge and three months later, and showed a 
trend towards doing so even 12 months after discharge. A more favourable SIR also 
predicted less social disability at 3 and 12 months after discharge. The associations 
were not explained by socio-demographic and clinical characteristics of the patients, 
which were controlled for as potential confounders. Also, there were no significant 
interaction effects with treatment setting or main psychiatric diagnosis in predicting 
outcomes. The study provides the most substantial evidence so far that SIR predicts 
outcomes in both hospital and day hospital settings and across all major psychiatric 
diagnostic groups. 
 
Strengths of the study include the large sample size, which allowed us to control for 
confounding variables and test interaction effects in a multivariate analysis; a long 
follow up period with several assessments at different points of time; and reasonable 
follow-up rates. The use of observer rated rather than self rated outcomes shows that 
 the association between SIR and outcomes can be explained neither by a consistent 
and general tendency of individuals for more positive or negative self ratings (5, 6, 
19), nor by a wish of patients to justify their initial views through providing 
corresponding outcome ratings. Furthermore, data was collected by researchers who 
were not involved in treatment, and data on SIR was collected on average six weeks 
before the first outcome assessment, thus minimizing the likelihood that a 
researcher’s awareness of a patients’ SIR could have influenced their outcome 
assessments. Finally, the study was conducted in five countries with the influence of 
the centre being controlled for in all analyses. 
 
A limitation of this study is that the findings are based on patients who are willing to 
participate in a research trial. This may have introduced a selection bias and it is 
unclear whether the results are generalisable to those patients who cannot be 
recruited to trials and do not participate in research interviews. Moreover, we tested 
the association of SIR with outcomes without considering mediating factors such as 
the actual treatments patients received in the hospital and day hospital and during 
the follow-up periods. 
 
The present findings represent a significant addition to the existing literature and 
provide much more substantive evidence on the predictive value of patients’ SIR to 
complex interventions than had been hitherto available (3, 14, 17, 18). A new finding 
is that SIR predicts outcomes not only at discharge or after a short follow-up period, 
but also for a longer period of one year. This is consistent with a recent study on 
involuntary patients who assessed their views of treatment on the CAT within one 
week of admission, thus using the same assessment instrument, but somewhat later 
after admission than in this study. One year after admission, patients with more 
positive initial views of treatment had fewer involuntary re-admissions and were more 
likely to see the original involuntary admission as justified (20). One may conclude 
 that patients’ views of treatment at early stages are associated with outcomes 
beyond discharge.  
 
In our study, the predictive value of SIR for symptom changes was not significant at 
one year, and thus seemed to diminish over time. Conversely, the predictive value of 
SIR for social disability was only significant at the two later follow-ups. This difference 
is likely to reflect the different nature of the two outcome criteria (21, 22). Whilst 
symptoms can fluctuate every day and be influenced short term, social disability is a 
more stable construct and usually requires more time for changes to materialise.  
 
In the absence of evidence on the processes mediating SIR and outcomes, one can 
only speculate about why and how a more positive SIR is linked to more favourable 
outcomes across settings and diagnostic groups. There are at least four explanations 
which are not mutually exclusive: A) A positive SIR may indicate a higher motivation 
of patients to adhere to subsequent treatments so that the association is mediated by 
a better adherence to pharmacological and psycho-social treatments in the hospital 
or day hospital and during the follow-up period (10). B) Patients’ SIR might reflect the 
quality of the therapeutic relationship between patients and treatment teams – as well 
as other non-specific factors - which can then directly or indirectly influence 
outcomes over time.  C) The SIR may also reflect an internal preparedness of the 
patient for positive change in the given situation and thus a better responsiveness to 
psychiatric treatment. D) SIR may be linked to patient characteristics that have not 
been assessed in this and other studies, such as personality traits that may predict 
longer term outcomes after an acute crisis.  
 
 
 
 
 Conclusion 
 
Although the explanation for the association of SIR and outcomes is unknown, the 
finding that patients’ outcomes up to a year later can be predicted simply by asking 
them within two days after admission whether they believe their treatment is right for 
them may be seen as astounding. It has clinical implications: patients’ views on the 
appropriateness of treatment are important and should be listened to even within the 
first two days after admission, when clinicians might think that patients have not yet 
had sufficient experience of the new treatment to form a useful judgment. Although 
patients may still struggle to settle into the new hospital or day hospital setting and 
symptom levels can be high, patients’ views of treatment are worth eliciting and 
listening to. SIR is easy to assess as part of routine clinical practice, and there is no 
reason to ignore such information that can be obtained at practically no cost. The 
association between SIR and outcome is not strong enough to make reliable 
predictions in individual cases. However, all other things being equal, clinicians may 
consider a positive SIR as a reassurance to continue with the current treatment plan, 
whilst a negative SIR may be a reason to consider changes to either the treatment 
setting or the specific treatment plan within it.  
 
Three major challenges arise for future research. The first is to identify the processes 
mediating the association between SIR and outcomes. In particular, the role of the 
therapeutic relationship, treatment adherence, and specific treatment components 
should be studied. The second task is to explore factors that may influence patients’ 
SIR, such as patients’ expectations and health beliefs, the way in which the treatment 
plan is presented to them, or the quality of the initial therapeutic contact with the 
service. Such research should control for patient characteristics that have been found 
to be associated with their SIR (7, 8). A third challenge is to develop interventions 
which aim to improve patients’ SIR to treatment, either by moderating factors in 
 patients’ initial treatment experience or by changing patients’ treatment plan to a 
more positively appraised one if they present a negative SIR.  The next step will be to 
test to what extent SIR can be influenced and whether a SIR that is more positive as 
a result of such interventions is still associated with more positive outcomes. A pilot 
study which identified patients with negative SIR in a day hospital and then provided 
treatment in line with their wishes showed encouraging results (15), but much wider 
and more systematic experimental research is warranted.  
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Table 1 Characteristics of the total sample (n=765) and CAT (Clients Assessment of 
Treatment) score on day 3 
 
 
 
Characteristics 
N or mean 
  
% or SD 
Centre, N (%)   
Czech Republic 170  22 
Germany 131  17 
Poland 217  28 
Slovakia 159 21 
United Kingdom  88 12 
Treatment setting, N (%)   
Inpatient care 374 49 
Day hospital care 391 51 
Length of stay (days), mean (SD) 66 62 
Gender, female, n (%) 481 63 
Age (years), mean (SD) 40 12 
Living alone, N (%) 121 16 
Education (years), mean (SD)                12 3 
Employed, N (%) 230 30 
ICD-10 diagnosis, N (%)   
Diagnosis F20-F29 218  29 
Diagnosis F30-F39 333 43 
Diagnosis F40-F59 214 28 
CAT score on day 3, mean (SD) 7.6 1.9 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table 2 Mean BPRS (Brief Psychiatric Rating Scale) and GSDS (Groningen Social 
Disabilities Schedule, Second Revision) scores at baseline, discharge, 3 months and 
12 months post-discharge 
 
Measure 
At 
Baseline 
At    
Discharge 
At 3 
months 
At 12 
months 
BPRS
     
N 765
 
686
 
606
 
541
 
Mean 46.7 34.9
 a 
37.2
ab 
36.2
abc 
SD 9.9 7.5 9.8 9.6 
GSDS
     
N 727                                                                          213
 
325
 
308
 
Mean 9.37 7.17
 a 
6.27
ab 
6.03
ab 
SD 0.54 3.93 4.56 4.74 
 
Results of paired t-tests: 
a Significant difference from baseline   (p<0.01) 
b Significant difference from discharge (p<0.01) 
c Significant difference from 3 months  (p<0.01) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 3 Main effects of subjective initial response and patient characteristics on BPRS score at discharge, month 3 and month 12 in mixed 
model analyses controlling for baseline symptom level, treatment setting and length of stay in hospital or day hospital 
 
 Discharge Month 3 Month 12 
Variables Coefficient 95% CI P Coefficient 95% CI P Coefficient 95% CI P 
Gender- female vs male -0.030 -0.076 0.016 0.196 -0.043 -0.107 0.020  0.178 0.016 -0.050 0.081 0.641 
Age (years)  0.002  0.000 0.004 0.063 0.003 0.000 0.005  0.040 0.001 -0.002 0.004 0.436 
Education (years) -0.004 -0.012 0.004 0.376 -0.001 -0.012 0.010  0.805 0.000 -0.012 0.011 0.962 
Living status - not alone vs alone  0.046 -0.017 0.108 0.151 0.019 -0.064 0.102  0.655 0.023 -0.065 0.111 0.611 
Employment status- employed vs unemployed  0.038 -0.011 0.087 0.124 0.067 0.000 0.133  0.049 0.066 -0.003 0.136 0.061 
ICD-10 Diagnosis             
F3 vs F2 -0.042 -0.098 0.015 0.15 -0.141 -0.219 -0.060 <0.001 -0.135 -0.216 -0.054 0.001 
F4 vs F2  0.006 -0.057 0.068 0.862 -0.011 -0.097 0.075  0.798 -0.076 -0.167 0.014 0.098 
Subjective Initial Response (CAT score on day 3) -0.019 -0.031 -0.007 0.033 -0.021 -0.038 -0.004  0.016 -0.016 -0.034 0.001 0.064 
 
 
 Table 4 Main effects of subjective initial response and patient characteristics on GSDS score at discharge, month 3 and month 12 in mixed 
model analyses controlling for baseline social disability level, treatment setting and length of stay in hospital or day hospital 
 
 Discharge Month 3 Month 12 
Variables Coefficient 95% CI P Coefficient 95% CI P Coefficient 95% CI P 
Gender- female vs male -0.065 -0.152 0.023 0.149 -0.041 -0.131  0.049 0.373  0.044 -0.053 0.142 0.375 
Age (years)  0.001 -0.002 0.005 0.461  0.002 -0.002  0.006 0.344  0.001 -0.003 0.005 0.580 
Education (years)  0.012 -0.146 0.171 0.375 -0.091 -0.244  0.062 0.243 -0.059 -0.222 0.104 0.478 
Living status - not alone vs alone  0.063 -0.053 0.179 0.287 -0.029 -0.151  0.092 0.638 -0.068 -0.202 0.067 0.322 
Employment status- employed vs unemployed  0.046 -0.049 0.142 0.338  0.089 -0.005  0.184 0.063     
ICD-10 Diagnosis             
F3 vs F2 -0.050 -0.156 0.055 0.350 -0.073 -0.184  0.037 0.194 -0.184 -0.305 -0.062 0.003 
F4 vs F2 -0.038 -0.158 0.082 0.535 -0.060 -0.180  0.060 0.324 -0.120 -0.253  0.012 0.075 
Subjective Initial Response (CAT score on day 3) -0.020 -0.044 0.004 0.108 -0.031 -0.056 -0.006 0.014 -0.029 -0.056 -0.003 0.031 
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